Evidence map›Paper›PMID 29423003›Full record

ArticleAmerican journal of translational research2018

Direct conversion of human fibroblasts into functional Leydig-like cells by

Yan-Ping Hou, Zhi-Yuan Zhang, Xiao-Yu Xing, Jin Zhou, Jie Sun

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yan-Ping HouDepartment of Urology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of MedicineShanghai, China.
Zhi-Yuan ZhangDepartment of Urology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of MedicineShanghai, China.
Xiao-Yu XingDepartment of Urology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of MedicineShanghai, China.
Jin ZhouDepartment of Urology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of MedicineShanghai, China.
Jie SunDepartment of Urology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of MedicineShanghai, China.
Shanghai Children's Medical Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The reprogramming of fibroblasts to induced pluripotent stem cells raises the possibility that a somatic cell can be reprogrammed to an alternative, differentiated fate without first becoming a stem/progenitor cell. Recent work has shown that fibroblasts can be reprogrammed to other, terminally differentiated cells with a combination of several transcription factors. Here, we report that a combination of four developmental transcription factors;

Indexed as

Human foreskin fibroblastsinduced Leydig-like cellsreprogramming

Identifiers

PMID29423003
PMCPMC5801356
OpenAlexW2982065622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.